Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
07-Aug-25 | Buy | Martin Diggle | 10.85p | 102,236 | £11,092.61 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
07-Aug-25 | Buy | Martin Diggle | 10.85p | 102,236 | £11,092.61 |
Notifier | Holding | Value* |
---|---|---|
Martin Diggle | 140,387,037 | £15,021,413 |
Jean-Michel Cosséry | 454,545 | £48,636 |
Lindy Durrant | 272,727 | £29,182 |
Notifier** | Holding | Value* |
---|---|---|
Redmile Group, LLC | 268,616,936 | £28,742,012 |
VULPES LIFE SCIENCES FUND | 117,729,029 | £12,597,006 |
VULPES LIFE SCIENCES FUND | 117,479,029 | £12,570,256 |
Ferlim Nominees Limited | 50,632,079 | £5,417,632 |
Reyker Nominees Ltd | 48,464,691 | £5,185,722 |
Hargreaves Lansdown | 33,619,839 | £3,597,323 |
Share Nominees Ltd. | 29,887,768 | £3,197,991 |
The Bank of New York Nominees Limited | 21,287,775 | £2,277,792 |
Legal & General Group Plc | 18,167,000 | £1,943,869 |
Nortrust Nominees Limited | 18,167,000 | £1,943,869 |
City Financial Investment Company Limited | 16,287,775 | £1,742,792 |
Barclayshare Nominees Ltd | 15,650,629 | £1,674,617 |
Lynchwood Nominees Ltd. | 15,085,721 | £1,614,172 |
Rock Nominees Limited | 13,445,702 | £1,438,690 |
Hygea VCT | 13,149,730 | £1,407,021 |
Huntress Nominees (CI) Limited | 11,309,220 | £1,210,086 |
Layton Trustees & L.G. Durrant | 8,773,960 | £938,814 |
JG Helfenstein | 7,000,000 | £749,000 |
Currency | UK Pounds |
Share Price | 10.70p |
Change Today | 0.20p |
% Change | 1.90 % |
52 Week High | 17.50p |
52 Week Low | 7.50p |
Volume | 2,073 |
Shares Issued | 1,037.78m |
Market Cap | £111.04m |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
09:09 | 227 @ 11.00p |
09:09 | 9 @ 11.00p |
09:09 | 1,819 @ 11.00p |
09:09 | 9 @ 11.00p |
09:09 | 9 @ 11.00p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research